Taplin, Mary Ellen
Harvard Medical School,
United States
2025 Rank: 42277
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1822 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42277 | 45549 |
| Total Cites | 30797 | 34994 |
| H-index | 63 | 65 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 211 | 217 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2971 | 3210 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 3740 | 4094 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19344 | 20863 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.68 |
| Self-Citation Percentage |
11.99%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2024 Rank: 40984
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1795 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40984 | 43033 |
| Total Cites | 28488 | 32457 |
| H-index | 61 | 65 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 207 | 213 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2906 | 3137 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 3617 | 3955 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17854 | 19291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.68 |
| Self-Citation Percentage |
12.23%
|
|
Taplin, Mary Ellen
Dana-Farber Cancer Institute,
United States
2023 Rank: 41099
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1816 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41099 | 43258 |
| Total Cites | 26097 | 29881 |
| H-index | 57 | 61 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 203 | 209 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2808 | 3036 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 3457 | 3791 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16298 | 17656 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.69 |
| Self-Citation Percentage |
12.66%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2022 Rank: 40209
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1803 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40209 | 43065 |
| Total Cites | 23129 | 26548 |
| H-index | 55 | 57 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 198 | 204 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2701 | 2925 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 3259 | 3572 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14450 | 15661 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.70 |
| Self-Citation Percentage |
12.88%
|
|
Taplin, Mary Ellen
Dana-Farber Cancer Institute,
United States
2021 Rank: 38828
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1739 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38828 | 42072 |
| Total Cites | 21716 | 24919 |
| H-index | 54 | 56 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 198 | 204 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2645 | 2866 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 3153 | 3454 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13624 | 14770 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.69 |
| Self-Citation Percentage |
12.85%
|
|
Taplin, Mary Ellen
Harvard Medical School,
United States
2020 Rank: 39164
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1828 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 39164 | 42719 |
| Total Cites | 18231 | 20921 |
| H-index | 51 | 51 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 193 | 199 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 2559 | 2767 |
| Number of Single+First+Last Authored Papers | 48 | 48 |
| Total Cites to Single+First+Last Authored Papers | 2977 | 3248 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11519 | 12495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.67 |
| Self-Citation Percentage |
12.86%
|
|